Medical therapies to prevent the development and progression of calcific aortic valve stenosis: a contemporary review [0.03%]
阻止和延缓钙化性主动脉瓣狭窄发生进展的药物治疗：综述文章
William A Courtney,Jarryd Walker,Aindreas Dorai-Raj et al.
William A Courtney et al.
Introduction: Aortic stenosis (AS), the leading cause of valvular heart disease related mortality, affects 12% of individuals over 75 years and is set to expand as the population ages. Once symptoms develop, severe sympto...
Retrograde type A aortic dissection following endovascular arch repair: what do clinicians need to be aware of? [0.03%]
主动脉腔内修复术后发生主动脉夹层逆向型A型脱垂：临床医生需要注意什么？
Dora Z Zatyko,Balazs C Lengyel,Alan B Lumsden
Dora Z Zatyko
Introduction: Retrograde Type A aortic dissection (RTAD) is a life-threatening complication following thoracic endovascular aortic repair (TEVAR) or hybrid arch repair. Expanding use of endovascular arch interventions has...
Optimal treatment choices for adult atrial septal defects: the role of appropriate risk stratification [0.03%]
成人房间隔缺损的最佳治疗选择：合适风险分层的作用
Umit Yasar Sinan,Neziha Aybuke Geylan,Arzu Bakimci Simsek et al.
Umit Yasar Sinan et al.
Introduction: Adult atrial septal defect (ASD) is no longer regarded as a benign congenital lesion, as long-term follow-up studies have demonstrated substantial risks of atrial arrhythmias, heart failure (HF), pulmonary h...
Hormone deficiency and cardiovascular disease: clinical impact, treatment strategies and prognostic prediction [0.03%]
激素缺乏与心血管疾病：临床影响、治疗策略和预后预测
Pedro Iglesias
Pedro Iglesias
Introduction: Hormone deficiency states are increasingly recognized as important, yet often underappreciated, contributors to cardiovascular (CV) disease. Deficits affecting pituitary, thyroid, parathyroid, adrenal, and g...
Association between pre-existing heart failure and in-hospital outcomes and management in admissions with cardiogenic shock [0.03%]
心源性休克入院患者原有心力衰竭与其住院结局和治疗之间的关联分析
Carlos Diaz-Arocutipa,Rafael Salguero-Bodes,Roberto Martín-Asenjo et al.
Carlos Diaz-Arocutipa et al.
Background: Cardiogenic shock (CS) remains highly lethal despite advances in care. Preexisting heart failure (HF) is common in CS, but its effect on outcomes and management is unclear. ...
Mineralocorticoids and outcome improvement in heart failure patients with and without atrial fibrillation: a systematic review and a meta-analysis [0.03%]
盐皮质激素受体拮抗剂对房颤和非房颤心力衰竭患者预后改善的影响：系统评价和荟萃分析
Bernadette Corica,Elisa Battigaglia,Giulio Francesco Romiti et al.
Bernadette Corica et al.
Background: The presence of atrial fibrillation (AF) in patients with heart failure (HF) is common and increases the risk of adverse events. Whether the benefit of mineralocorticoid receptor antagonists (MRAs) in patients...
Beyond successful atrial fibrillation ablation: unmet patient needs, quality-of-life gap and patients' perspective [0.03%]
超越成功的房颤消融术：未满足的患者需求，生活质量差距和患者的视角
Andrea Matteucci,Marco Valerio Mariani,Luca Sgarra et al.
Andrea Matteucci et al.
Percutaneous coronary intervention in high-bleeding risk patients: a review of contemporary management strategies [0.03%]
高出血风险患者的经皮冠状动脉介入治疗：当代管理策略述评
Giuseppe Andò,Giulia Cavolina,Alessio Villari et al.
Giuseppe Andò et al.
Introduction: High bleeding risk (HBR) affects over one-third of patients undergoing percutaneous coronary intervention (PCI) and is associated with elevated mortality due to both hemorrhagic and ischemic complications. O...
Strategic targeting of mitochondria in ischemic heart disease: mechanisms and emerging therapies [0.03%]
缺血性心脏病中线粒体的靶向策略：机制与新兴疗法
Gino A Kurian,Eren Rose Gino
Gino A Kurian
Introduction: Ischemic heart disease (IHD) remains a leading cause of global morbidity and mortality. Mitochondrial dysfunction is central to ischemia - reperfusion injury, contributing to bioenergetic failure, oxidative ...
Clinical approaches for determining idiopathic and inflammatory dilated cardiomyopathy in women [0.03%]
用于鉴别诊断女性特发性和炎症性扩张型心肌病的临床方法
Andrea Silvio Giordani,Caterina Menghi,Matteo Castegnaro et al.
Andrea Silvio Giordani et al.